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Abstract
Background: Acute hospitalisation and delirium have individually been shown to adversely affect trajectories of cognitive
decline but have not previously been considered together. is work aimed to explore the impact on cognition of hospital
admission with and without delirium, compared to a control group with no hospital admissions.
Methods: e Delirium and Cognitive Impact in Dementia (DECIDE) study was nested within the Cognitive Function
and Ageing Study II (CFAS II)–Newcastle cohort. CFAS II participants completed two baseline interviews, including the
Mini-Mental State Examination (MMSE). During 2016, surviving participants from CFAS II–Newcastle were recruited to
DECIDE on admission to hospital. Participants were reviewed daily to determine delirium status. During 2017, all DECIDE
participants and age, sex and years of education matched controls without hospital admissions during 2016 were invited to
repeat the CFAS II interview. Delirium was excluded in the control group using the Informant Assessment of Geriatric
Delirium Scale (i-AGeD). Linear mixed effects modelling determined predictors of cognitive decline.
Results: During 2016, 82 of 205 (40%) DECIDE participants had at least one episode of delirium. At 1 year, 135 of 205
hospitalised participants completed an interview along with 100 controls. No controls experienced delirium (i-AGeD>4).
Delirium was associated with a faster rate of cognitive decline compared to those without delirium (β = −2.2, P < 0.001),
but number of hospital admissions was not (P = 0.447).
Conclusions: ese results suggest that delirium during hospitalisation rather than hospitalisation per se is a risk factor for
future cognitive decline, emphasising the need for dementia prevention studies that focus on delirium intervention.







niversity of Exeter user on 07 M
ay 2021
S. J. Richardson et al.
Key Points
• Hospital admission without delirium was not associated with cognitive decline compared with a control group without
hospitalisation.
• Delirium during hospital admission was associated with significant cognitive decline.
• ese results suggest that delirium may be a key component of the cognitive decline observed after hospitalisation.
• ese results emphasise the need for dementia prevention studies that focus on delirium intervention.
Introduction
ere is much interest in the impact of hospitalisation on
older people, particularly in respect of cognition. In a num-
ber of large studies, acute hospitalisation has been shown
to be adversely associated with increased risks of incident
dementia and accelerated trajectories of cognitive decline [1–
6]. e components driving these associations are unclear
but factors demonstrated to confer increased risk of worse
cognitive outcomes following hospitalisation include non-
elective admission [1, 2], critical illness [3, 4], admissions
for medical conditions [2] and stroke [5], longer admissions
[4] along with a number of baseline comorbidities [6].
Delirium is emerging as a significant independent risk
factor for future cognitive impairment [7, 8], but the con-
tribution of delirium to the cognitive decline described
following hospitalisation has not previously been considered
[6]. It is possible that much of the relationship between hos-
pitalisation and cognitive decline is attributable to delirium.
Advancing our understanding of the components driving
the adverse impact on cognition of hospitalisation, and the
potential contribution of delirium, will facilitate the design
of targeted interventions to prevent dementia. Delirium is
an attractive potential target given that it has been shown to
be potentially modifiable [9].
We set out to quantify the relative contribution of hospi-
talisation per se and delirium episodes on cognitive outcomes
in a prospective, longitudinal cohort. In secondary analysis
using data from the Delirium and Cognitive Impact in
Dementia (DECIDE) study, a population-based study of
cognitive outcomes in older people following delirium, we
compared cognitive outcomes in those hospitalised with and
without delirium, with a control group with no hospital
admissions. We hypothesised that people who were hospi-
talised and did not have delirium would not differ in their
cognitive trajectory from those who were not hospitalised.
Methods
Study design and participants
e DECIDE study was a prospective, longitudinal cohort
study aiming to examine the effects of delirium upon
cognition [10]. To account for baseline cognitive function,
DECIDE was nested within the Cognitive Function and
Ageing Study II–Newcastle cohort (CFAS II–Newcastle).
CFAS II is a large, population-based cohort of people
aged ≥65 years from three geographical areas in the UK:
Cambridgeshire, Nottingham and Newcastle upon Tyne
[11]. For wave 1 of CFAS II-Newcastle, 2,582 participants
were interviewed between February 2009 and November
2011. Two years later, 1751 of these participants were
re-interviewed for wave 2.
Between 5 January 2016 and 5 January 2017, surviving
participants from CFAS II–Newcastle, with and without
dementia, were invited to take part in DECIDE on admis-
sion to hospital as an emergency or electively.e study team
were alerted to admissions by a Recurring Admission Patient
Alert applied to the electronic medical records of CFAS II-
Newcastle participants. If the participant themselves lacked
capacity, an appropriate personal consultee was requested to
provide written confirmation of willingness to participate.
Once recruited, participants were seen on each subsequent
hospital admission during the study period. Participants
were excluded if they lacked capacity to consent and we
were unable to identify or contact an appropriate personal
consultee; they were receiving end-of-life care; they were
being isolated for infection control reasons; or if they were
expected to be in hospital for fewer than 24 h.
All participants from DECIDE were invited for follow-
up 1 year after their hospital admissions to complete the
CFAS II interview for a third time (wave 3). In addition, 100
control participants from CFAS II-Newcastle who had not
been admitted to hospital during 2016, matched for age, sex
and years of education to DECIDE participants, were also
interviewed.
Exposures
During 2016, consented individuals were reviewed daily for
delirium during hospital admissions using a standardised
approach based on DSM 5, described within the published
DECIDE protocol [10, 12]. If consented participants
could not be seen for any reason during their admissions,
medical notes were reviewed using a validated tool to
look for evidence of delirium [13]. Delirium status during
the preceding year in those not admitted to hospital was
ascertained during the home interview using the Informant
Assessment of Geriatric Delirium Scale (I-AGeD) with a
cut-off >4 indicating delirium [14].
Outcomes
e primary outcome used for this work was the Mini-
Mental State Examination (MMSE) score recorded as part
of the CFAS II interviews at waves 1, 2 and 3. e full
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(http://www.cfas.ac.uk/). Delirium symptoms were assessed
as part of the CFAS II interviews. Using an algorithm based
upon these responses, designed specifically for use within this
cohort, delirium status at the time of the wave 3 interview
was determined [15].
Statistical analysis
Participants were divided into three groups: no hospitali-
sation, hospitalisation without delirium and hospitalisation
with delirium. Between-groups differences, when evaluating
all three groups as a whole, were evaluated using a one-way
analysis of variance or Kruskall–Wallis test, as appropriate.
Independent t-test, Mann–Whitney or chi-squared test were
used when comparing two groups. Bonferroni correction
was used for multiple comparisons. Within R, lme4 was
used to perform linear mixed effects modelling (LMEM) to
determine change in MMSE using piecewise linear growth
from wave 1 and wave 2 of CFAS II assessments (time
1), and from wave 2 to DECIDE follow-up wave 3 (time
2). is was to account for a change point after wave 2,
where participants were recruited to the DECIDE study
following admissions to hospital in 2016. For comparison,
change in MMSE was also modelled with time as a linear
function (from waves 1, 2 and 3, Supplementary Table 2).
is form of multilevel modelling is suitable for longitudinal
data analysis because of its ability to handle missing data,
as it does not exclude subjects with missing data from the
analysis. Rate of change was modelled for all participants
with baseline age, years of education, sex, time, number of
hospital admissions and delirium diagnosis as fixed effects,
in addition to interactions with time and age (age x time),
hospital admissions (number of admissions x time) and
delirium (delirium x time). A random intercept and slope
model was used, which varied at the participant level and
accounted for by time variation.is analysis was repeated to
include duration of hospital stay (total numbers of days spent
in hospital in 2016) to determine whether length of hospital
stay has an impact on cognitive decline. Statistical analyses
were performed using STATA Version 16 and R software
(Version 3.6.0; R Foundation for Statistical Computing,
Vienna, Austria).
Results
A total of 363CFAS II-Newcastle participants were admitted
to hospital during 2016. Of these, 280 were eligible for the
DECIDE study and 205 were recruited (73%) [16]. In total,
82 participants (40%) had at least one episode of delirium
during the 1 year study period.
At 1 year follow-up forDECIDE (mean of 6.8± 0.7 years
since CFAS II wave 1 interview), 38 participants had
died; 135 of the remaining 167 participants completed
assessments (81%) with 32 participants refusing follow-
up. ree participants, who all experienced delirium,
were unable to complete the MMSE due to advanced
dementia. Participants who did not return for 1 year
follow-up had significantly poorer MMSE scores at wave
1 (mean = 26.5± 2.8 vs. 27.3± 2.8, respectively, P = 0.020)
and wave 2 (mean = 25.7± 3.2 vs. 26.7± 3.2,
respectively, P = 0.015), but did not differ in terms of
baseline age, sex or years of education (P > 0.05 for
all, Supplementary Table 1). No participants met the criteria
for delirium at the time of the wave 3
interview.
A total of 100 of the 187 control participants approached
from CFAS II-Newcastle, with no hospital admissions dur-
ing 2016, were recruited and interviewed (53%); all controls
completed the MMSE. No controls experienced delirium
according to the i-AGeD tool.
Table 1 shows the baseline characteristics of the sample
stratified by group: hospitalisation and delirium, hospitali-
sation no delirium and no hospitalisation. Participants who
developed delirium were significantly older and more cogni-
tively impaired than those who did not (Bonferroni correc-
tion P < 0.017 for all, Table 1). Participants with delirium
spent more days in hospital compared to those without
delirium (P < 0.010). ere was no significant difference in
baseline or follow-up MMSE and a similar rate of decline in
participants with no hospital admissions compared to those
with hospital admissions but no delirium (P > 0.05 for all).
By comparison, participants with a hospital admission and
delirium have a lower baseline MMSE (P < 0.017). Trajec-
tories of MMSE change between these three groups are illus-
trated in Figure 1. All groups show cognitive decline between
baseline (wave 1) and follow-up (wave 3). Participants with
delirium had a steeper rate of cognitive decline between
waves 2 and 3 compared to those who were not admitted
to hospital and those who were admitted to hospital but did
not have delirium.
LMEM determined associations with MMSE from
baseline to follow-up, with a change point after wave 2,
controlling for age, sex and years of education (Table 2).
e number of hospital admissions was not associated
with MMSE score or cognitive decline (P > 0.05 for all).
Participants with delirium had poorer cognition at all time
points (β =−1.1, P = 0.002). Between wave 1 and 2 (time
1), participants who developed delirium had a faster rate of
cognitive decline compared to those without delirium by
0.9 points on the MMSE (β =−0.9, P = 0.004). is rate
of decline increased to 2.2 points on the MMSE between
wave 2 and wave 3 (time 2) compared to those who did
not have delirium during the DECIDE study (β =−2.2,
P < 0.001).
As participants with delirium spent significantly longer
in hospital compared to those who did not have delirium,
this analysis was repeated to include the total number of
days spent in hospital (Supplementary Table 3). e total
duration of hospital stay was not significantly associated with
cognitive decline at time 1 or time 2 (P > 0.05 for both).
However, as shown in the previous analysis, participants with
delirium had a faster rate of cognitive decline compared to
those without delirium (time 1: β =−0.7, P = 0.046; time 2:
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Table 1. Characteristics of participants within the three groups—hospitalisation and delirium, hospitalisation without
delirium and no hospitalisation during 2016
Hospitalisation,
delirium (n = 48)
Hospitalisation, no
delirium (n = 87)
No hospitalisation
(n = 100)
F/Z/χ 2 P value
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Age at wave 1, years 79.1 (6.0) 74.5 (5.9) 75.6 (5.5) 10.4 <0.001 a,b
Female, n (%) 26 (54.2%) 48 (55.2%) 55 (55.0%) 0.0 0.989
Years of education 10.1 (1.7) 10.5 (1.9) 10.8 (2.6) 4.3 0.111
Number of hospital admissions during 2016 2.1 (0.1) 2.1 (.02) N/A -1.5 0.125
Total number of days spent in hospital during
2016, median (IQR)
23.0 (21.5) 5.0 (7.0) N/A -6.3 <0.001
MMSE score wave 1 26.2 (3.3) 27.9 (2.2) 28.0 (1.9) 15.7 <0.001a,b
MMSE score wave 2 25.2 (3.9) 27.4 (2.5) 28.0 (1.9) 25.1 <0.001 a,b
MMSE score at follow-up interview (wave 3)† 21.8 (5.8) 26.7 (3.2) 27.2 (2.9) 35.5 <0.001 a,b
Data presented are mean (SD) unless otherwise stated, post hoc Bonferroni correction for three group comparison at P < 0.017, a Hospitalisation, delirium vs. Hospitalisation,
no delirium, b Hospitalisation, delirium vs. No hospitalisation, No significant differences were found between Hospitalisation, no delirium vs. No hospitalisation.
MMSE=Mini-Mental State Examination, IQR= interquartile range. † n = 3 participants with delirium were unable to complete MMSE at follow-up due to advanced
dementia.
Figure 1. Line graphs comparing MMSE change over time in participants with no hospitalisation (not admitted), hospitalisation
without delirium and hospitalisation with delirium. Time (assessment): 0 = baseline assessment (wave 1), 1 = first follow-up
assessment (wave 2), 2 = second follow-up assessment (wave 3). Delirium status ascertained during a 1 year period between wave
2 and wave 3.
Discussion
In a representative, population-based sample of older peo-
ple, hospital admission without delirium was not associ-
ated with cognitive decline compared with a control group
without hospitalisation. However, having delirium during
hospital admission was associated with a 2.2 points reduc-
tion in global cognitive function assessed using the MMSE
compared to those without delirium. Taken together, these
results suggest that delirium may be a key component of the
cognitive decline observed after hospitalisation.
Previous studies demonstrating a link between hospital-
isation and cognitive decline have not considered delirium
[1–6]. It is possible that the negative impact of hospi-
talisation on cognition demonstrated in these studies was
due to delirium. Our results provide new insights into the
relationship between hospitalisation and cognitive decline in
older people by demonstrating that not all were at increased
risk of cognitive decline and that delirium during a hos-
pital admission seemed to differentiate between those at
increased risk of cognitive decline and those who were not.
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Table 2. Predictors of cognitive decline using the MMSE over time using piece-wise growth
Variables in model β SE df t-value P value
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intercept 29.4 2.0 407.4 14.6 <0.001 ∗∗∗
Age (years) -0.05 0.02 428.4 -2.1 0.033 ∗
Sex (female) 0.2 0.3 304.3 0.8 0.445
Education (years) 0.2 0.1 304.7 3.7 <0.001 ∗∗∗
Time 1 2.2 1.5 305.0 1.4 0.160
Time 2 5.8 2.7 272.3 2.1 0.034 ∗
Delirium -1.1 0.4 429.2 -3.1 0.002 ∗∗
No. hospital admissions -0.1 0.1 429.3 -0.7 0.502
Age x Time 1 -0.03 0.02 305.0 -1.5 0.145
Age x Time 2 -0.09 0.04 271.9 -2.4 0.017 ∗
Delirium x Time 1 -0.9 0.3 305.0 -2.9 0.004 ∗∗
Delirium x Time 2 -2.2 0.6 265.4 -3.7 <0.001 ∗∗∗
No. hospital admissions x Time 1 -0.1 0.1 305.0 -1.2 0.244
No. hospital admissions x Time 2 -0.1 0.2 267.4 -0.8 0.447
Significant results highlighted in bold. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 MMSE=Mini-Mental State Examination. Time 1 =wave 1 to wave 2 assessments, Time
2 =wave 2 to wave 3 assessments. Delirium status ascertained during a 1 year period during Time 2 (wave 2 to wave 3 assessments).
admission, as the DECIDE study captured all elective and
emergency admissions over 24 h duration, despite previ-
ous studies demonstrating worse outcomes in non-elective,
critical illness and medical admissions [1–4].
As opposed to Sprung et al . [2] our study found that
number of hospitalisations was not associated with cognitive
decline . We additionally found that although the partic-
ipants with delirium spent more days in hospital during
the 1 year study period, total duration of hospital stay was
not associated with cognitive decline in our models. is
difference may be due to the inclusion of delirium as a
variable within our modelling or due to the considerably
longer period over which admissions were captured and
followed up by Sprung et al .
It is possible that hospitalisation itself may have effects in
people with delirium as a change of environment can precip-
itate or worsen delirium, and the management of delirium at
homemay be associated with improved outcomes. A study of
community-managed delirium would be necessary to exam-
ine this but would be extremely challenging as participants
would need to be assessed in the home to determine and
account for differences in duration and severity of delirium
in those managed at home compared with those managed in
hospital.
e associations we have demonstrated between baseline
cognitive impairment and delirium, along with delirium
and subsequent cognitive decline, are in line with previous
population-based studies in older people [7, 8]. It is not
known whether delirium is specifically causing the cogni-
tive decline described in this and other studies, or simply
a manifestation of acute, severe illness and/or underlying
co-morbidities. e DECIDE study was the first study to
robustly attempt to address this by demonstrating that delir-
ium was strongly associated with cognitive decline, even
when accounting for illness severity, frailty and comorbidity
[16]. e DECIDE study strengthened the argument for
a causative relationship by showing that greater delirium
exposure, in terms ofmore days with delirium,more episodes
of delirium and more severe delirium were all associated
with worse cognitive outcomes. e underlying mechanism
by which delirium may cause worsening cognition is not
known, but could include stress responses, effects of medica-
tion andmultiplicative effects on underlying neuropathology
[17].
Study strengths and limitations
A strength of DECIDE was the prospective assessments
during 2016 and the standardised approach to delirium
ascertainment. Nesting DECIDE within an existing, well-
characterised, population-based cohort with known baseline
cognition was also an advantage, as baseline cognition could
be accounted for when quantifying cognitive outcomes in
a representative sample. e study had a number of lim-
itations. First, while it is the biggest prospective study of
its kind to date, it is nonetheless a single-centre sample
and our sample size was smaller than previous population-
based studies exploring the effects of hospitalisation [6].
e DECIDE study was powered to look at the effects
of delirium rather than comparing the group hospitalised
without delirium with those not hospitalised. It remains
possible that a larger sample size may have detected smaller
changes in cognition in those hospitalised without delir-
ium. e sample size also limited the subgroup analysis
which could be performed, including comparing cogni-
tive outcomes in incident versus prevalent delirium. Sec-
ondly, the data only capture hospitalisations and delirium
during 2016 and it is possible that a number of people
in the ‘no hospitalisation’ group could have been admit-
ted to hospital or had delirium in preceding years. How-
ever, misclassification of this kind suggests our estimates
are likely to be conservative. Finally, there was a consider-
able gap between wave 2 interviews, completed in 2013,
and follow-up interviews in 2017 (wave 3), although we
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Clinical significance
Despite being present in at least 15% of older people in
hospital, delirium is often missed by clinical teams [18].
As well as being associated with considerable mortality and
worse functional outcomes [19], our study demonstrates
that delirium is a key marker of adverse cognitive outcomes
following hospitalisation.is emphasises the importance of
recognising delirium. Previous work has shown that delir-
ium is modifiable, but further work is required focused
on whether delirium intervention, in the form of both
prevention and treatment, prevents cognitive decline [9]. It
is also possible that rehabilitation following delirium may
ameliorate some of the effects of delirium but more studies
on interventions to promote recovery from delirium are
needed [20].
Conclusions
Hospital admission without delirium was not associated
with cognitive decline, with cognitive trajectories equiva-
lent to those without a hospital admission. Delirium dur-
ing hospitalisation was associated with significant cognitive
decline, suggesting that it is delirium during hospitalisa-
tion rather than hospitalisation alone that is a risk factor
for future cognitive decline. is emphasises the urgent
need for dementia prevention studies that focus on delirium
intervention.
Supplementary Data: Supplementary data mentioned in
the text are available to subscribers in Age and Ageing online.
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